PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAcamprosate
Acamprosate
Acamprosate (acamprosate) is a small molecule pharmaceutical. Acamprosate was first approved as Campral on 2004-07-29. It is used to treat alcoholism in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
chemically-induced disordersD064419
mental disordersD001523
Trade Name
FDA
EMA
Acamprosate (discontinued: Acamprosate, Campral)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Acamprosate calcium
Tradename
Company
Number
Date
Products
CAMPRALForest LaboratoriesN-021431 DISCN2004-07-29
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
acamprosate calciumANDA2025-02-20
campralNew Drug Application2016-08-06
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
alcoholismEFO_0003829D000437F10.1
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
N07: Other nervous system drugs in atc
N07B: Drugs used in addictive disorders
N07BB: Drugs used in alcohol dependence
N07BB03: Acamprosate
HCPCS
No data
Clinical
Clinical Trials
48 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AlcoholismD000437EFO_0003829F10.118313529
Alcohol drinkingD000428EFO_00043292125
DepressionD003863F33.91124
SchizophreniaD012559EFO_0000692F20213
Anxiety disordersD001008EFO_0006788F41.11113
Major depressive disorderD003865EFO_0003761F22123
Depressive disorderD003866EFO_1002014F32.A123
Bipolar disorderD001714EFO_0000289F30.91112
Psychotic disordersD011618F20.8111
GamblingD005715EFO_1001926F63.011
Show 2 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DementiaD003704EFO_0003862F0311
Psychophysiologic disordersD011602F45.911
Somatoform disordersD013001F4511
BulimiaD002032F50.2111
Feeding and eating disordersD001068F50111
Binge-eating disorderD056912F50.2111
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Fragile x syndromeD005600Q99.2213
SyndromeD013577123
Alzheimer diseaseD000544EFO_0000249F0322
Alcohol-related disordersD019973F1011
Healthy volunteers/patients11
Liver diseasesD008107EFO_0001421K70-K7711
Tourette syndromeD005879EFO_0004895F95.211
Tardive dyskinesiaD000071057G24.0111
DyskinesiasD020820G2411
Autism spectrum disorderD000067877F84.011
Show 3 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
TinnitusD014012H93.111
Autistic disorderD001321EFO_0003758F84.011
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Parkinson diseaseD010300EFO_0002508G2011
Compulsive behaviorD003192R46.8111
AnxietyD001007EFO_0005230F41.111
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAcamprosate
INNacamprosate
Description
Acamprosate calcium is an organic calcium salt. It contains an acamprosate(1-).
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(=O)NCCCS(=O)(=O)O
Identifiers
PDB
CAS-ID77337-76-9
RxCUI
ChEMBL IDCHEMBL1201293
ChEBI ID51041
PubChem CID155434
DrugBankDB00659
UNII IDN4K14YGM3J (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Acamprosate
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 3,864 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
701 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use